Robert Wessman to speak at UBS pharmaceuticals conference
The CEO of Actavis generic pharmaceuticals, Robert Wessman, is scheduled to speak at the annual UBS Global Specialty and Generic Pharmaceuticals Confe...
Actavis pharmaceuticals strengthens retail presence in Australia
Actavis, a generic pharmaceuticals company based in Iceland, has signed a distribution agreement for a number of retail products with Australian compa...
Harvard publishes case study on Actavis pharmaceuticals
Actavis, a generic pharmaceuticals company based in Iceland, last week announced that Harvard Business School had produced a case study on the company...
Actavis launches skin products in Romania
Actavis, the Iceland-based generic pharmaceuticals company, recently launched its popular Decubal skin products in Romania. The 17 products, which are...
Icelandic billionaire rushed to Bulgarian hospital
Bjorgolfur Thor Bjorgolfsson, a well-known Icelandic businessman and Iceland’s first billionaire, was taken to hospital in Bulgaria last week complain...
Actavis buys Chinese API manufacturing firm
Actavis, a leading generic pharmaceuticals company, has acquired a 90% share in Zhejiang Chiral Medicine Chemicals Company in China for an undisclosed...
Green light for Actavis cancer drug
Actavis, a generic pharmaceuticals company, has been given the go ahead to distribute the oncology drug, Irinotecan Hydrochloride Injection, in the US...
Actavis buys Pfizer oncology plant
Actavis, an international pharmaceutical firm which is based in Iceland, recently signed an agreement to acquire a manufacturing site from Pfizer in N...